12/20/2024 6:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/09/2024 5:04 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/06/2024 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/03/2024 5:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/20/2024 5:02 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/19/2024 5:01 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2024 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
11/08/2024 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/07/2024 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/29/2024 6:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024 5:11 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024 5:15 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024 5:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2024 5:15 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2024 5:07 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2024 3:00 PM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/09/2024 5:13 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2024 5:10 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/04/2024 5:11 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/25/2024 5:06 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/18/2024 6:43 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2024 5:02 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2024 5:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024 5:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024 5:35 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2024 5:01 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024 5:07 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024 5:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024 5:02 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2024 5:51 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024 7:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
03/21/2024 8:20 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/21/2024 5:01 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2024 5:33 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024 6:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2024 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/21/2024 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/06/2024 4:00 PM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 424B5 | |
02/06/2024 4:05 PM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad) You don’t actually want to buy Bitcoin this time around.
That’s because there’s a better way to take advantage of this new bull market…
One market expert calls it Crypto’s Hidden Gem
And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin…
That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky…
This is a much safer and better approach to ride this years’ crypto bull run.
Because believe it or not…
The 2024 crypto bull run is one you DON’T want to miss. Click Here to get the full details about Crypto’s Hidden Gem |
01/16/2024 11:15 PM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form EFFECT | |
01/12/2024 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/05/2024 5:09 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/04/2024 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/04/2024 5:01 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |